7-Bromo-3,4-dihydroquinazolin-2(1H)-one
CAS: 1207175-68-5
Ref. 3D-HYB17568
| 1g | To inquire | |
| 5g | To inquire | |
| 100mg | To inquire | |
| 250mg | To inquire | |
| 500mg | To inquire |
Product Information
7-Bromo-3,4-dihydroquinazolin-2(1H)-one is a new atypical antipsychotic. It has been shown to have 5-HT1A receptor antagonist activity, and d2 receptor agonist activity. 7-Bromo-3,4-dihydroquinazolin-2(1H)-one has been shown to be an effective agent for the treatment of schizophrenia in animal models. This drug has also been shown to have antidepressant effects in rats, suggesting that it may have additional therapeutic effects. The mechanism of 7-bromo 3,4 dihydroquinazolin-2(1H) one is not fully understood but is thought to involve the reduction of quinazoline by reductive amination with tertiary amines followed by cyclization with piperazine or other heterocycles.
Chemical properties
Technical inquiry about: 3D-HYB17568 7-Bromo-3,4-dihydroquinazolin-2(1H)-one
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
